Speciality Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Education Dialogues
    • Business Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Speciality Medical Dialogues
    • Editorial
    • News
        • Anesthesiology
        • Cancer
        • Cardiac Sciences
        • Critical Care
        • Dentistry
        • Dermatology
        • Diabetes and Endo
        • Diagnostics
        • ENT
        • Featured Research
        • Gastroenterology
        • Geriatrics
        • Medicine
        • Nephrology
        • Neurosciences
        • Nursing
        • Obs and Gynae
        • Ophthalmology
        • Orthopaedics
        • Paediatrics
        • Parmedics
        • Pharmacy
        • Psychiatry
        • Pulmonology
        • Radiology
        • Surgery
        • Urology
    • Practice Guidelines
        • Anesthesiology Guidelines
        • Cancer Guidelines
        • Cardiac Sciences Guidelines
        • Critical Care Guidelines
        • Dentistry Guidelines
        • Dermatology Guidelines
        • Diabetes and Endo Guidelines
        • Diagnostics Guidelines
        • ENT Guidelines
        • Featured Practice Guidelines
        • Gastroenterology Guidelines
        • Geriatrics Guidelines
        • Medicine Guidelines
        • Nephrology Guidelines
        • Neurosciences Guidelines
        • Obs and Gynae Guidelines
        • Ophthalmology Guidelines
        • Orthopaedics Guidelines
        • Paediatrics Guidelines
        • Psychiatry Guidelines
        • Pulmonology Guidelines
        • Radiology Guidelines
        • Surgery Guidelines
        • Urology Guidelines
    LoginRegister
    Speciality Medical Dialogues
    LoginRegister
    • Home
    • Editorial
    • News
      • Anesthesiology
      • Cancer
      • Cardiac Sciences
      • Critical Care
      • Dentistry
      • Dermatology
      • Diabetes and Endo
      • Diagnostics
      • ENT
      • Featured Research
      • Gastroenterology
      • Geriatrics
      • Medicine
      • Nephrology
      • Neurosciences
      • Nursing
      • Obs and Gynae
      • Ophthalmology
      • Orthopaedics
      • Paediatrics
      • Parmedics
      • Pharmacy
      • Psychiatry
      • Pulmonology
      • Radiology
      • Surgery
      • Urology
    • Practice Guidelines
      • Anesthesiology Guidelines
      • Cancer Guidelines
      • Cardiac Sciences Guidelines
      • Critical Care Guidelines
      • Dentistry Guidelines
      • Dermatology Guidelines
      • Diabetes and Endo Guidelines
      • Diagnostics Guidelines
      • ENT Guidelines
      • Featured Practice Guidelines
      • Gastroenterology Guidelines
      • Geriatrics Guidelines
      • Medicine Guidelines
      • Nephrology Guidelines
      • Neurosciences Guidelines
      • Obs and Gynae Guidelines
      • Ophthalmology Guidelines
      • Orthopaedics Guidelines
      • Paediatrics Guidelines
      • Psychiatry Guidelines
      • Pulmonology Guidelines
      • Radiology Guidelines
      • Surgery Guidelines
      • Urology Guidelines
    • Home
    • News
    • Cardiac Sciences
    • Omega 3 supplements do...

    Omega 3 supplements do not benefit heart health : Cochrane Review

    Written by Medha Baranwal Baranwal Published On 2018-07-18T20:00:39+05:30  |  Updated On 18 July 2018 8:00 PM IST
    Omega 3 supplements do not benefit heart health : Cochrane Review

    Contrary to popular belief that consumption of omega-3 supplements is a simple way to protect the heart, Cochrane researchers in a meta-analysis of trials in over 100,000 people have found little proof that it prevented heart disease. Omega 3 fish oil supplements are taken by millions of people worldwide in a bid to improve their brain and heart health. However, contrary to the belief of their benefits against heart disease, a new Cochrane systematic review published in the Cochrane Library has found that omega 3 supplements are of little or no use at all for the prevention of stroke, heart attacks or deaths.


    Omega-3 is a family of fats that include:

    • ALA (alpha-linolenic acid) - which the body can't make for itself but is found in vegetable oils, nuts and seeds

    • EPA (eicosapentaenoic acid) and DHA (docosahexaenoic acid) - which the body can make from ALA but are also present in oily fish and fish oils, including cod liver oil


    In addition to some brands of bread, milk, yogurt and spreads extra omega-3 usually AHA) is added. The international study involved the analysis of seventy-nine randomized trials comprising of about 112,059 subjects.


    Lee Hooper from the University of East Anglia, UK, and colleagues conducted the study to assess the effects of additional omega 3 fat consumption, compared to lower or usual omega 3, on heart disease and circulation.


    Read Also: Omega 3 supplements don’t improve reading skills or memory in school children

    The consumption of omega 3 fats is promoted globally due to the belief that it provides protection against heart disease by lowering cholesterol or lowering blood pressure. They are readily available as over-the-counter supplements and are widely used and bought.


    Twenty-five studies out of 79 were assessed as highly trustworthy for the review because they were well designed and conducted.


    The studies recruited women and men from Asia, Australia, Europe and North America. Some of them were healthy and others had some existing illnesses. The participants were assigned to increase their intake of omega 3 fats or to maintain their usual intake of fat for at least a year.


    Most studies investigated the impact of giving a long-chain omega 3 supplements in a capsule form and compared it to a dummy pill. Only a few assessed whole fish intake. Most ALA trials added omega 3 fats to foods such as margarine and gave these enriched foods, or naturally ALA-rich foods such as walnuts, to people in the intervention groups, and usual (non-enriched) foods to other participants.


    Key Findings:

    • Increasing long-chain omega 3 provides little if any benefit on most outcomes that were looked at.

    • The researchers found high certainty evidence that long-chain omega 3 fats had little or no meaningful effect on the risk of death from any cause.

    • The risk of death from any cause was 8.8% in people who had increased their intake of omega 3 fats, compared with 9% in people in the control groups.

    • Taking more long-chain omega 3 fats (including EPA and DHA), primarily through supplements probably makes little or no difference to the risk of cardiovascular events, coronary heart deaths, coronary heart disease events, stroke or heart irregularities.

    • Long-chain omega 3 fats probably did reduce some blood fats, triglycerides, and HDL cholesterol.

    • Reducing triglycerides is likely to be protective of heart diseases, but reducing HDL has the opposite effect.

    • Increasing long-chain omega 3 or ALA probably does not affect body weight or fatness.

    • Eating more ALA through food or supplements probably has little or no effect on cardiovascular deaths or deaths from any cause. However, eating more ALA probably reduces the risk of heart irregularities from 3.3 to 2.6%.

    • Reductions in cardiovascular events with ALA were so small that about 1000 people would need to increase consumption of ALA for one of them to benefit.


    "We can be confident in the findings of this review which go against the popular belief that long-chain omega 3 supplements protect the heart. This large systematic review included information from many thousands of people over long periods. Despite all this information, we don't see protective effects, said Dr. Hooper.


    "The review provides good evidence that taking long-chain omega 3 (fish oil, EPA or DHA) supplements do not benefit heart health or reduce our risk of stroke or death from any cause. The most trustworthy studies consistently showed little or no effect of long-chain omega 3 fats on cardiovascular health. On the other hand, while oily fish is a healthy food, it is unclear from the small number of trials whether eating more oily fish is protective of our hearts.


    "This systematic review did find moderate evidence that ALA, found in plant oils (such as rapeseed or canola oil) and nuts (particularly walnuts) may be slightly protective of some diseases of the heart and circulation. However, the effect is very small, 143 people would need to increase their ALA intake to prevent one person developing an arrhythmia. One thousand people would need to increase their ALA intake to prevent one person dying of coronary heart disease or experiencing a cardiovascular event. ALA is an essential fatty acid, an important part of a balanced diet, and increasing intakes may be slightly beneficial for prevention or treatment of cardiovascular disease."


    For more reference log on to http://dx.doi.org/10.1002/14651858.CD003177

    BraincholesterolCochrane LibrarydeathDHAdiseasedocosahexaenoic acidEicosapentaenoic AcidfatfishFish oilHealthHeartheart-attackLee HooperOmega-3strokesupplement
    Source : With inputs from Cochrane Library

    Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

    Medha Baranwal Baranwal
    Medha Baranwal Baranwal
      Show Full Article
      Next Story
      Similar Posts
      NO DATA FOUND

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 12 Oct 2022 7:06 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok